Join this interesting discussion on “Investments into global HC systems” at the #swissbiotechday2024 today (22nd April) at 17:30 in the “Sydney” room at the Congress Center, Basel. Our CEO, Sitara Merchant, will share her thoughts on the importance of #HCinvestments in bridging #healthprotectiongap especially in the #LICs and #MICs, role of #inclusivefinance in expanding access to #healthcare and how relevant stakeholders can complement each other’s work to maximise the impact and help build #resilientcommunities. More info here 👉 https://lnkd.in/d9R-bHyj #swissbiotechday #biotechnology #healthcareinvestment #healthfinancing #financialinclusion #healthequity
Director / International Business Development / Global Location and Site Selection Analyst
I am excited about this year’s Swiss Biotech Day 2024 – we’ll discuss together with - Dr. Lutz Hegemann President, Global Health & Sustainability, Novartis - Michael Altorfer, CEO, Swiss Biotech Association - Dr. Jörg Schläpfer, Head Intl. Relations, Swissmedic - Sitara Merchant, CEO, Swiss Capacity Building Facility (SCBF) in particular the topic about “Investments into global HC systems” on Monday, 22 April at 17:30 in room “Sydney” of the Congress Center Basel. HC investments are engines of economic growth, social equity, and political stability. The Swiss life sciences industry, together with Swiss government organizations, academic institutions, and Swiss-based non-profit organizations, plays a key role in HC programs around the world. To further maximize the ROI of HC spending on a global scale, a more synchronized approach among Swiss stakeholders is needed. Come and join us! https://lnkd.in/ebbnru7c #swissbiotechday #swissbiotechday2024 #biotechnology #investments
